1. Von Willebrand Factor in Health and Disease
- Author
-
Sergei K. Trufanov, P. P. Avdonin, A. A. Tsitrina, Pavel V. Avdonin, E. Yu. Rybakova, Nikolay V. Goncharov, and N. V. Tsvetaeva
- Subjects
chemistry.chemical_classification ,congenital, hereditary, and neonatal diseases and abnormalities ,Metalloproteinase ,biology ,Chemistry ,Biophysics ,Cell Biology ,medicine.disease ,Biochemistry ,ADAMTS13 ,Cell biology ,Von Willebrand factor ,hemic and lymphatic diseases ,Hemostasis ,cardiovascular system ,biology.protein ,medicine ,Platelet ,Thrombus ,Receptor ,Glycoprotein ,circulatory and respiratory physiology - Abstract
Abstract— Von Willebrand factor (vWF), the key component of hemostasis, is synthesized in endothelial cells and megakaryocytes and released into the blood as high molecular weight multimeric glycoproteins weighing up to 20 million Daltons. Blood plasma metalloprotease ADAMTS13 cleaves ultra-large vWF multimers to smaller multimeric and oligomeric molecules. The vWF molecules attach to the sites of damage at the surface of arterioles and capillaries and unfold under conditions of shear stress. On the unfolded vWF molecule, the regions interacting with receptors on the platelet membrane are exposed. After binding to the vWF filaments, platelets are activated; platelets circulating in the vessels are additionally attached to them, leading to thrombus formation, blocking of microvessels, and cessation of bleeding. This review describes the history of the discovery of vWF, presents data on the mechanisms of vWF secretion and its structure, and characterizes the processes of vWF metabolism in the body under normal and pathological conditions.
- Published
- 2021
- Full Text
- View/download PDF